A comprehensive review on the risks assessment and treatment options for Sarcopenia in people with diabetes
Authors
Johri, NishantVengat, Maheshwari
Kumar, Deepanshu
Nagar, Priya
John, Davis
Dutta, Shubham
Mittal, Piyush
Affiliation
Teerthanker Mahaveer College of Pharmacy; University of ChesterPublication Date
2023-07-30
Metadata
Show full item recordAbstract
This comprehensive review aims to examine the reciprocal interplay between Type 2 diabetes mellitus (T2DM) and sarcopenia, identify prevailing research gaps, and discuss therapeutic approaches and measures to enhance healthcare practices within hospital settings. A thorough literature review was conducted to gather relevant studies and articles on the relationship between T2DM and sarcopenia. Various databases were searched, including Google Scholar, PubMed, Scopus, and Science Direct databases. The search terms included T2DM, sarcopenia, inflammation, insulin resistance, advanced glycation end products, oxidative stress, muscle dimensions, muscle strength, muscle performance, aging, nutrition, hormone levels, and physical activity. The collected articles were critically analysed to extract key findings and identify gaps in current research. The prevalence and incidence of metabolic and musculoskeletal disorders, notably T2DM and sarcopenia, have surged in recent years. T2DM is marked by inflammation, insulin resistance, accumulation of advanced glycation end products, and oxidative stress, while sarcopenia involves a progressive decline in skeletal muscle mass and function. The review underscores the age-related correlation between sarcopenia and adverse outcomes like fractures, falls, and mortality. Research gaps regarding optimal nutritional interventions for individuals with T2DM and sarcopenia are identified, emphasizing the necessity for further investigation in this area. The reciprocal interplay between T2DM and sarcopenia holds significant importance. Further research is warranted to address knowledge gaps, particularly in utilizing precise measurement tools during clinical trials. Lifestyle modifications appear beneficial for individuals with T2DM and sarcopenia. Additionally, practical nutritional interventions require investigation to optimize healthcare practices in hospital settings. The online version contains supplementary material available at 10.1007/s40200-023-01262-w. [Abstract copyright: © The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.]Citation
Johri, N., Vengat, M., Kumar, D., Nagar, P., John, D., Dutta, S., & Mittal, P. (2023). A comprehensive review on the risks assessment and treatment options for Sarcopenia in people with diabetes. Journal of Diabetes & Metabolic Disorders, 22(2), 995-1010. https://doi.org/10.1007/s40200-023-01262-wPublisher
Springer NatureAdditional Links
https://link.springer.com/article/10.1007/s40200-023-01262-wType
ArticleDescription
This article is not available on ChesterRepEISSN
2251-6581ae974a485f413a2113503eed53cd6c53
10.1007/s40200-023-01262-w